| Tryptamine Therapeutics Limited (TYP) ORDINARY FULLY PAID |
Health Care |
- |
Landmark EEG Biomarker Agreement for Precision Psychiatry
|
21 Aug 2025 8:58AM |
$0.033 |
$0.034 |
risen by
3.03%
|
|
TYP - Price-sensitive ASX Announcement
Full Release
Key Points
- Tryptamine Therapeutics Limited announced a collaboration with MindBio Therapeutics Corp.
- The agreement grants TYP access to MindBio’s EEG Brain Mapping AI Biomarker Platform.
- This technology helps predict patient responses to psychedelic medicines using EEG data and AI analysis.
- TYP will use the biomarker platform in its precision psychiatry clinical programs.
- The partnership aims to enable more personalized and effective mental health treatments.
- Integrating AI-powered biomarkers is expected to optimize clinical trial success and accelerate therapy delivery.
- The collaboration signifies TYP’s strategic focus on innovation and advanced neurotechnology in mental healthcare.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$5,193 |
FY25 Results Presentation
|
21 Aug 2025 8:57AM |
$6.930 |
$7.880 |
risen by
13.71%
|
|
DOW - Price-sensitive ASX Announcement
Full Release
Key Points
- EBIT increased by 26.7% to $453.2 million.
- Net profit after tax rose by 36.5% to $264.7 million.
- Total revenue decreased by 9% to $10,885.7 million.
- Achieved $213 million in cost reductions, exceeding targets.
- Significant divestments included Keolis Downer and non-core businesses.
- Shift towards a services-led model, exiting mining and construction.
- Focus on operational improvements and risk management.
- Transformation program aimed at sustainable growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$5,193 |
FY25 Results Presentation
|
21 Aug 2025 8:57AM |
$6.930 |
$7.880 |
risen by
13.71%
|
|
DOW - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying EBITA increased by 24.5% to $474.2 million.
- Strong cash conversion rate of 98% was maintained.
- Substantial statutory EBIT and NPAT growth.
- Successful implementation of a $213 million cost-out program.
- Strategic exits from low-margin operations and divestments were executed.
- The balance sheet was strengthened, supporting future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$46 |
MVP Announces FY25 Full Year Results
|
21 Aug 2025 8:57AM |
$0.635 |
$0.405 |
fallen by
36.22%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Medical Developments International Limited (MVP) announced its full-year results for FY25.
- Revenue for the year was reported at $22.9 million, with a net loss after tax of $7.5 million.
- The company experienced growth in its Penthrox business, with international sales increasing due to new market entries and expansion in existing markets.
- Domestic sales were impacted by ongoing challenges in the Australian market, including regulatory delays and competitive pressures.
- MVP invested in research and development, regulatory submissions, and clinical trials to support pipeline products and expand Penthrox indications.
- Operating expenses increased due to higher investment in commercialization activities, international expansion, and regulatory costs.
- The company highlighted progress in its partnership strategies, including collaborations with major pharmaceutical companies for global distribution.
- Cash reserves were managed through a combination of capital raising and operational cost controls.
- The outlook for FY26 includes continued focus on international market expansion, product innovation, and improving operational efficiencies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Naos Emerging Opportunities Company Limited (NCC) ORDINARY FULLY PAID |
Financials |
$28 |
Appendix 4G & Corporate Governance Statement
|
21 Aug 2025 8:57AM |
$0.340 |
$0.385 |
risen by
13.24%
|
|
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$46 |
FY25 Full Year Results
|
21 Aug 2025 8:57AM |
$0.635 |
$0.405 |
fallen by
36.22%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant revenue growth and improved financial performance in FY25.
- Focused strategy on core business areas, especially pain management and Penthrox.
- Reduction of net loss and improvement in operating margins.
- Disciplined cost management and supply chain optimization.
- Continued investment in regulatory submissions and international expansion.
- Management reiterated a clear vision for sustainable long-term shareholder value.
- Emphasis on innovation and operational excellence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| National Storage REIT (NSR) ORDINARY FULLY PAID |
Real Estate |
- |
NSR 2025 Results Presentation
|
21 Aug 2025 8:56AM |
$2.440 |
$2.790 |
risen by
14.34%
|
|
| Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID |
Health Care |
$10,498 |
Preliminary Final Report
|
21 Aug 2025 8:56AM |
$28.740 |
$21.240 |
fallen by
26.10%
|
|
SHL - Price-sensitive ASX Announcement
Full Release
Key Points
- Sonic Healthcare Limited reported a revenue of A$9,645,448,000 for the year ended 30 June 2025, showing a growth of 7.6%.
- Profit after tax attributable to members was A$513,597,000, a slight increase of 0.5% from the previous year.
- The effective tax rate for the year was 27.6%, slightly higher than the previous guidance due to jurisdictional variances.
- Cash generated from operations was significantly higher, owing to a 48% reduction in income taxes paid, compared to previous years.
- Dividends were declared with a final dividend of 63 cents per share and an interim dividend of 44 cents per share.
- Sonic Healthcare completed the acquisition of Laboratory Group Dr. Kramer & Colleagues on 1 July 2025.
- The company experienced operational disruptions in the USA due to a cyber event impacting billing and debt collection.
- Guidance for FY2026 includes expected EBITDA in the range of A$1.87 to A$1.95 billion.
- Net tangible asset backing per ordinary security was reported at $(2.69).
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID |
Health Care |
$10,498 |
Preliminary Final Report
|
21 Aug 2025 8:56AM |
$28.740 |
$21.240 |
fallen by
26.10%
|
|
SHL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 7.6% to $9,645,448,000.
- Profit after tax attributable to members was $513,597,000.
- Total equity at the end of the financial year was $8,473,216,000.
- Final dividend declared at 63 cents per share.
- Major revenue from laboratory services.
- Consistent shareholder returns policy with suspended Dividend Reinvestment Plan.
- Emphasized strategic growth through acquisitions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gateway Mining Limited (GML) ORDINARY FULLY PAID |
Materials |
$114 |
Trading Halt
|
21 Aug 2025 8:55AM |
$0.028 |
$0.049 |
risen by
75%
|
|
GML - Price-sensitive ASX Announcement
Full Release
Key Points
- Gateway Mining Limited (GML) has requested a trading halt from the ASX.
- The trading halt is sought pending an announcement about a proposed capital raising.
- The trading halt will be effective from 29 May 2023.
- The halt will last until the earlier of the announcement being made or market open on 31 May 2023.
- The purpose of the halt is to ensure a fair and informed market.
- The company's request is in accordance with ASX Listing Rule 17.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$46 |
FY25 Full Year Results Investor Presentation
|
21 Aug 2025 8:55AM |
$0.635 |
$0.405 |
fallen by
36.22%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 full year financial results show strong revenue growth and improved EBITDA.
- Pain Management segment, led by Penthrox, remains the primary growth driver.
- International market expansion, especially in Europe and Asia-Pacific, is progressing well.
- Investments continue in regulatory approvals, research, and new product development.
- Strategic partnerships and ongoing clinical trials support long-term growth.
- Supply chain and regulatory challenges remain but are being actively managed.
- Board commits to disciplined capital management and reinvestment in key business areas.
- Positive outlook for revenue growth and operational improvements in the coming year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,102 |
Update - Notification of buy-back - WHC
|
21 Aug 2025 8:54AM |
$6.430 |
$7.420 |
risen by
15.40%
|
|
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$5,193 |
FY25 Results Media Release
|
21 Aug 2025 8:54AM |
$6.930 |
$7.880 |
risen by
13.71%
|
|
DOW - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory NPAT of $149.1 million, an 81.6% increase.
- Underlying NPATA growth of 33% to $279.4 million.
- EBITA margin of 4.4%, highest in over 10 years.
- Net debt to EBITDA improved to 0.9x.
- Cash conversion rate of 97.9%.
- Final dividend of 14.1 cps, fully franked.
- Announcement of $230 million share buy-back.
- Strategic divestments and focus on core growth.
- Plans for digitization and AI investments in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$5,193 |
FY25 Results Media Release
|
21 Aug 2025 8:54AM |
$6.930 |
$7.880 |
risen by
13.71%
|
|
DOW - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory NPAT of $149.1 million, up 81.6% from the prior year
- Underlying NPATA of $279.4 million, a 33% increase
- Improved EBITA margin to 4.4%
- Declared a fully franked final dividend of 14.1 cents per share
- Announced $230 million share buyback
- Net debt to EBITDA improved to 0.9x
- Completed divestments for portfolio simplification
- Focus on core markets and growth opportunities
- Entering FY26 with stable market conditions
- Plans for modernisation and targeting sustainable growth
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infinity Mining Limited (IMI) ORDINARY FULLY PAID |
Materials |
$4 |
IRGS Gold Targets defined at Tanjil Bren & Walhalla South
|
21 Aug 2025 8:54AM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
IMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Infinity Mining Limited (IMI) has advanced exploration at Tanjil Bren and Walhalla South in the Central Victorian Goldfields, confirming the presence of Intrusion-Related Gold System (IRGS) targets.
- A comprehensive review and analysis of recent and historical exploration data has led to the identification of several new gold targets with IRGS affinities.
- The Tanjil Bren project area contains multiple gold prospects, with geological similarities to the Fosterville and Costerfield gold deposits.
- Field mapping, sampling, and geochemical surveys have delineated areas of strong gold anomalism associated with intrusive-related alteration zones.
- The company has prioritized drill targets based on geochemical, geophysical, and structural criteria for further testing.
- Walhalla South has also shown significant potential with multiple gold prospects identified, supported by historical mining records and recent sampling results.
- IMI plans to undertake further fieldwork, including geophysics and drilling, to test the newly defined IRGS targets and refine their exploration models.
- The company highlights the potential for large-scale, high-grade gold mineralization in both project areas due to their geological setting and exploration results.
- Community engagement and compliance with regulatory frameworks are stated as ongoing priorities for the exploration programs.
- IMI reaffirms its commitment to systematic exploration to unlock value from these prospective gold projects in Victoria.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NAOS Small Cap Opportunities Company Limited (NSC) ORDINARY FULLY PAID |
Financials |
$44 |
Dividend/Distribution - NSC
|
21 Aug 2025 8:54AM |
$0.340 |
$0.330 |
fallen by
2.94%
|
|
| Charter Hall Group (CHC) STAPLED SECURITIES US PROHIBITED |
Real Estate |
$10,567 |
Appendix 4G
|
21 Aug 2025 8:53AM |
$22.820 |
$22.340 |
fallen by
2.10%
|
|
| NAOS Ex-50 Opportunities Company Limited (NAC) ORDINARY FULLY PAID |
Financials |
$24 |
Dividend/Distribution - NAC
|
21 Aug 2025 8:53AM |
$0.540 |
$0.530 |
fallen by
1.85%
|
|
| Charter Hall Group (CHC) STAPLED SECURITIES US PROHIBITED |
Real Estate |
$10,567 |
Corporate Governance Statement
|
21 Aug 2025 8:53AM |
$22.820 |
$22.340 |
fallen by
2.10%
|
|
| Orica Limited (ORI) ORDINARY FULLY PAID |
Materials |
$10,963 |
Update - Notification of buy-back - ORI
|
21 Aug 2025 8:53AM |
$21.680 |
$23.650 |
risen by
9.09%
|
|
| IDT Australia Limited (IDT) ORDINARY FULLY PAID |
Health Care |
$14 |
FY25 Appendix 4G and Corporate Governance Statement
|
21 Aug 2025 8:53AM |
$0.069 |
$0.032 |
fallen by
53.62%
|
|
| Kingsland Minerals Ltd (KNG) ORDINARY FULLY PAID |
Materials |
$5 |
Leliyn Produces 99.97% Purified Spherical Graphite
|
21 Aug 2025 8:53AM |
$0.145 |
$0.051 |
fallen by
64.83%
|
|
KNG - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingsland Minerals Ltd achieved 99.97% purified spherical graphite at the Leliyn Project.
- Graphite concentrate was processed by ProGraphite in Germany using advanced purification methods.
- The spherical graphite produced meets specifications for lithium-ion battery anodes.
- High yields and low impurity levels were recorded during the test program.
- The Leliyn Project could become a major source of battery-grade graphite.
- Kingsland is advancing a scoping study and further downstream product development.
- Test results validate the suitability of Leliyn graphite for premium anode material.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,102 |
Extension of On-market Share Buy-back
|
21 Aug 2025 8:52AM |
$6.430 |
$7.420 |
risen by
15.40%
|
|
WHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Whitehaven Coal Limited extends on-market share buy-back program.
- Up to $48 million of shares to be repurchased.
- Buy-back period is from 22 August to 31 December 2025.
- Part of updated Capital Allocation Framework.
- Targets payout ratio of 40-60% of underlying Group NPAT.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,102 |
Extension of On-market Share Buy-back
|
21 Aug 2025 8:52AM |
$6.430 |
$7.420 |
risen by
15.40%
|
|
WHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Whitehaven Coal Limited extends on-market share buy-back.
- Up to $48 million of shares to be repurchased.
- Buy-back period from 22 August to 31 December 2025.
- Part of the updated Capital Allocation Framework.
- Aims for a 40-60% payout ratio of underlying Group NPAT.
- Balance between fully franked dividends and share buy-backs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tetratherix Limited (TTX) ORDINARY FULLY PAID |
Health Care |
$184 |
Notification regarding unquoted securities - TTX
|
21 Aug 2025 8:52AM |
$4.070 |
$6.250 |
risen by
53.56%
|
|
Call 1300 880 160
Start a chat
Schedule a call
